Literature DB >> 2304461

Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F.

F Rozen1, I Edery, K Meerovitch, T E Dever, W C Merrick, N Sonenberg.   

Abstract

The mechanism of ribosome binding to eucaryotic mRNAs is not well understood, but it requires the participation of eucaryotic initiation factors eIF-4A, eIF-4B, and eIF-4F and the hydrolysis of ATP. Evidence has accumulated in support of a model in which these initiation factors function to unwind the 5'-proximal secondary structure in mRNA to facilitate ribosome binding. To obtain direct evidence for initiation factor-mediated RNA unwinding, we developed a simple assay to determine RNA helicase activity, and we show that eIF-4A or eIF-4F, in combination with eIF-4B, exhibits helicase activity. A striking and unprecedented feature of this activity is that it functions in a bidirectional manner. Thus, unwinding can occur either in the 5'-to-3' or 3'-to-5' direction. Unwinding in the 5'-to-3' direction by eIF-4F (the cap-binding protein complex), in conjunction with eIF-4B, was stimulated by the presence of the RNA 5' cap structure, whereas unwinding in the 3'-to-5' direction was completely cap independent. These results are discussed with respect to cap-dependent versus cap-independent mechanisms of ribosome binding to eucaryotic mRNAs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304461      PMCID: PMC360981          DOI: 10.1128/mcb.10.3.1134-1144.1990

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Capping of eucaryotic mRNAs.

Authors:  A J Shatkin
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

2.  A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5'-terminal cap in mRNA.

Authors:  N Sonenberg; M A Morgan; W C Merrick; A J Shatkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

3.  Nonspecific effect of m7GMP on protein-RNA interactions.

Authors:  N Sonenberg; A J Shatkin
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

4.  Introduction of homologous DNA sequences into mammalian cells induces mutations in the cognate gene.

Authors:  K R Thomas; M R Capecchi
Journal:  Nature       Date:  1986 Nov 6-12       Impact factor: 49.962

5.  Probing the function of the eucaryotic 5' cap structure by using a monoclonal antibody directed against cap-binding proteins.

Authors:  N Sonenberg; D Guertin; D Cleveland; H Trachsel
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

6.  Interaction of Escherichia coli dnaB and dnaC(D) gene products in vitro.

Authors:  S Wickner; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

7.  Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells.

Authors:  H Trachsel; N Sonenberg; A J Shatkin; J K Rose; K Leong; J E Bergmann; J Gordon; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  5'-terminal structure of poliovirus polyribosomal RNA is pUp.

Authors:  M J Hewlett; J K Rose; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

9.  The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np.

Authors:  A Nomoto; Y F Lee; E Wimmer
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

10.  Absence of 5' terminal capping in encephalomyocarditis virus RNA.

Authors:  D Frisby; M Eaton; P Fellner
Journal:  Nucleic Acids Res       Date:  1976-10       Impact factor: 16.971

View more
  255 in total

1.  Characterization and mutational analysis of yeast Dbp8p, a putative RNA helicase involved in ribosome biogenesis.

Authors:  M C Daugeron; P Linder
Journal:  Nucleic Acids Res       Date:  2001-03-01       Impact factor: 16.971

2.  Characterization of the cold stress-induced cyanobacterial DEAD-box protein CrhC as an RNA helicase.

Authors:  E Yu; G W Owttrim
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

3.  Cap-independent translation conferred by the 5' leader of tobacco etch virus is eukaryotic initiation factor 4G dependent.

Authors:  D R Gallie
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Ski7p G protein interacts with the exosome and the Ski complex for 3'-to-5' mRNA decay in yeast.

Authors:  Y Araki; S Takahashi; T Kobayashi; H Kajiho; S Hoshino; T Katada
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 5.  The target of rapamycin (TOR) proteins.

Authors:  B Raught; A C Gingras; N Sonenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Computational modeling of eukaryotic mRNA turnover.

Authors:  D Cao; R Parker
Journal:  RNA       Date:  2001-09       Impact factor: 4.942

7.  Escherichia coli DbpA is an RNA helicase that requires hairpin 92 of 23S rRNA.

Authors:  C M Diges; O C Uhlenbeck
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

8.  The requirement for eukaryotic initiation factor 4A (elF4A) in translation is in direct proportion to the degree of mRNA 5' secondary structure.

Authors:  Y V Svitkin; A Pause; A Haghighat; S Pyronnet; G Witherell; G J Belsham; N Sonenberg
Journal:  RNA       Date:  2001-03       Impact factor: 4.942

9.  Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.

Authors:  A Pandita; M Zielenska; P Thorner; J Bayani; R Godbout; M Greenberg; J A Squire
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

10.  Mtt1 is a Upf1-like helicase that interacts with the translation termination factors and whose overexpression can modulate termination efficiency.

Authors:  K Czaplinski; N Majlesi; T Banerjee; S W Peltz
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.